Over the last 12 months, one SurgePays, Inc. officers and board members picked up shares in open-market trades, about $83,000 in total, and none of them sold.
May David Allen (Director) made the biggest buy, worth around $45,000.
36 investment managers listed SURG in their latest 13F filings (Q2 2026); more funds bought than sold. No open-market insider buying or selling in the last full quarter. Insiders bought in 3 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | May David Allen | Director | Buy | 121 | $0.53 | $64 | SEC |
| Jun 5, 2026 | May David Allen | Director | Buy | 34,716 | $0.53 | $18K | SEC |
| Jun 5, 2026 | May David Allen | Director | Buy | 5,413 | $0.53 | $3K | SEC |
| Dec 11, 2025 | May David Allen | Director | Buy | 10,000 | $1.62 | $16K | SEC |
| Dec 11, 2025 | May David Allen | Director | Buy | 28,422 | $1.60 | $45K | SEC |
| Jun 10, 2025 | May David Allen | Director | Sell | 63,000 | $2.81 | $177K | SEC |
| May 19, 2025 | Cox Kevin Brian | CEO | Buy | 15,073 | $2.75 | $41K | SEC |
| Dec 4, 2024 | Evers Anthony George | CFO | Sell | 36,666 | $1.86 | $68K | SEC |
| Dec 4, 2024 | Cox Kevin Brian | CEO | Sell | 35,180 | $1.82 | $64K | SEC |
| Nov 25, 2024 | Weisberg Laurie | Director | Buy | 2,808 | $1.70 | $5K | SEC |
| Nov 25, 2024 | Weisberg Laurie | Director | Buy | 1 | $1.67 | $2 | SEC |
| Nov 25, 2024 | Weisberg Laurie | Director | Buy | 301 | $1.83 | $551 | SEC |
| Nov 25, 2024 | Weisberg Laurie | Director | Buy | 100 | $1.84 | $184 | SEC |
| Nov 25, 2024 | Weisberg Laurie | Director | Buy | 1,500 | $1.84 | $3K | SEC |
| Nov 25, 2024 | Weisberg Laurie | Director | Buy | 3,099 | $1.84 | $6K | SEC |
In the last 12 months SurgePays, Inc. insiders made open-market purchases worth about $83,000 and sales worth about $0. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in SURG was filed on 2026-06-05.
36 investment managers reported holding SURG in SEC Form 13F filings for Q2 2026.
No congressional trades in SURG were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).